Slingshot Biosciences

About Slingshot Biosciences

Slingshot Biosciences is dedicated to providing precision-engineered cell mimic reference controls for flow cytometry and related applications. Their mission is to bring greater precision, consistency, and reliability to assays by offering high-performance synthetic cell mimics that outperform traditional biological and polystyrene bead controls, enhancing research outcomes in biotechnology and related fields.

Products & Services

TruCytes™ Biomarker Controls:Precision-engineered cell mimics for mimicking and quantifying specific cell types and functions with customizable proteins, ensuring reliable assay validation.

Custom TruCytes™:Tailored cell mimic solutions designed to meet specific research needs for biomarker validation and assay accuracy.

TruCytes™ Potency:Controls designed to assess potency in assays with high precision and reliability.

TruCytes™ Lymphocyte Subsets Control:Cell mimics for controlling and validating lymphocyte subset analysis in flow cytometry.

TruCytes™ CD19 Quant:Quantitative controls for CD19 biomarker analysis, enhancing assay accuracy.

Single Biomarker Controls:Controls focused on individual biomarkers for standardized monitoring and validation.

SpectraComp Compensation Controls:Superior controls for compensation and unmixing in flow cytometry, mimicking real cell staining.

ViaComp Cell Health Controls:Controls to assess cell viability using DNA intercalating and amine-reactive dyes.

FlowCytes Calibration Controls:Calibration controls for setting standards in instrument traceability and performance.

Specialties

Flow Cytometry Cell Therapy Diagnostics Clinical Trials Cell Mimic Technology Biomarker Controls Assay Validation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A3 T: - FT: Series A3	A: 11000000 MR: - FA: 11 million FAN: 11000000	D: 2023-02-06 FD: 2023-02-06	2 investors

Series A3 Latest

2023-02-06

$11.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Glenn Bilawsky

Chief Executive Officer

LinkedIn (Pro only)

T

Tiffany Salas-Morris

Chief Commercial Officer

LinkedIn (Pro only)

N

Nimisha Srivastava

Chief Operating Officer

LinkedIn (Pro only)

J

Jeffrey Kim

Founder, Board Director

A

Andrew Lee

Board Director

P

Patrick Weiss

Board Director

View 8 more team members with Pro

Unlock Full Team Directory

Recent News